Oncogenic Osteomalacia Caused by a Phosphaturic Mesenchymal Tumor of the Oral Cavity: A Case Report

We report a case of oncogenic osteomalacia associated with a phosphaturic mesenchymal tumor in a 31-year-old woman. She was presented with severe generalized bone and muscle pain and was restricted to bed. She lost 20cm in height over the 8 years since she had first noticed a pain in her thigh. A walnut-sized, hard, soft tissue tumor was found very easily beside her lower molar teeth. Radiologic examination revealed a remarkable decrease in bone density and multiple pathologic fractures of spine, femur and phalangeal bones. Severe hypophosphatemia, hyperphosphaturia, low plasma 1,25-dihydroxyvitamin D3 level and high plasma PTH level were disclosed at presentation. Histomorphometric examination revealed an extensive area of unmineralized osteoid and little mineralizing activity. A pharmacologic dose of 1α-hydroxyvitamin D3 or 1,25-dihydroxyvitamin D3 slightly increased the serum phosphate level and renal tubular reabsorption of phosphate, and slightly decreased plasma PTH level without any symptomatic improvement. Histologic examination of the tumor revealed a mixed connective tissue tumor that consisted of central woveh bones and surrounding primitive spindle cells with prominent vascularities. After removal of the tumor, all biochemical, hormonal and radiologic abnormalities disappeared with remarkable symptomatic improvement.

• Publication year

  1997

• Venue

  The Korean Journal of Internal Medicine

• Publication date

  1997-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3904/kjim.1997.12.1.89PMID 9159046PMCID 4531958
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells

  2007cited by this paper
• Bone scan in tumor-induced osteomalacia.

  1995cited by this paper
• Molecular biology of hypophosphataemic rickets and oncogenic osteomalacia

  1994cited by this paper
• Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia.

  1994cited by this paper
• Review and update: oncogenic osteomalacia-rickets.

  1991cited by this paper
• Tumor-Induced Osteomalacia: Pre- and Postoperative Biochemical Findings

  1990cited by this paper
• Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3.

  1989cited by this paper
• Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity.

  1988cited by this paper
• Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets

  1987cited by this paper
• Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia. Effect of successful tumor resection on mineral homeostasis.

  1987cited by this paper
• Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases.

  1985cited by this paper
• Oncogenic osteomalacia: strange tumours in strange places.

  1985cited by this paper
• Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases.

  1984cited by this paper
• Oncogenic hypophosphatemic osteomalacia.

  1983cited by this paper
• Mandibular tumor-induced muscular weakness and osteomalacia.

  1981cited by this paper
• Tumor-induced vitamin D-resistant hypophosphatemic osteomalacia associated with proximal renal tubular dysfunction and 1,25-dihydroxyvitamin D deficiency.

  1979cited by this paper
• Osteomalacia Due to 1α,25-Dihydroxycholecalciferol Deficiency: ASSOCIATION WITH A GIANT CELL TUMOR OF BONE

  1977cited by this paper
• Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions.

  1977cited by this paper
• Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone.

  1977cited by this paper
• Rheumatic manifestations of hypophosphatemia.

  1974cited by this paper

• A literature review to understand the burden of disease in people living with tumour-induced osteomalacia

  2022cites this paper
• Phosphaturic Mesenchymal Tumor in the Maxillofacial Region: A Diagnostic Dilemma

  2021cites this paper
• Ameloblastic Fibroodontoma of Mandible Causing Tumor Induced Osteomalacia: A Case Report with Review of 88 Phosphaturic Oral Neoplasms

  2021cites this paper
• Clinical, histopathologic, subtype, and immunohistochemical analysis of jaw phosphaturic mesenchymal tumors

  2020cites this paper
• Tumor induced osteomalacia in head and neck region: single center experience and systematic review

  2019cites this paper
• Tumor‐induced hypophosphatemic osteomalacia caused by a mesenchymal tumor of the mandible managed by a segmental mandibulectomy and microvascular reconstruction with a free fibula flap

  2019cites this paper
• Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review

  2018cites this paper
• Ethmoid-Nasal Phosphaturic Mesenchymal Tumour

  2018cites this paper
• Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck

  2016cites this paper
• Sinonasal Phosphaturic Mesenchymal Tumor: A Rare and Misinterpreted Entity

  2015cites this paper
• Sinonasal phosphaturic mesenchymal tumor: Case report and systematic review

  2014cites this paper
• Tumor induced osteomalacia: a forgotten paraneoplastic syndrome?

  2012cites this paper
• Tumor-induced osteomalacia.

  2011cites this paper
• Mesenchymal phosphaturic neoplasm in the maxillary sinus: a case report.

  2010cites this paper
• Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.

  2009cites this paper
• Kumarsen Cooper

  2008cites this paper
• Phosphaturic mesenchymal tumor diagnosed by fine‐needle aspiration and core biopsy: A case report and review of literature

  2008cites this paper
• Oncogenic osteomalacia: induced by tumor, cured by surgery.

  2007cites this paper
• Phosphaturic mesenchymal tumor (mixed connective tissue variant): a case report with spectral analysis

  2006cites this paper
• Oncogenic osteomalacia in a case with a maxillary sinus mesenchymal tumor.

  2006cites this paper
• The Role of Fibroblast Growth Factor 23 in Phosphate Homeostasis

  2004influential citation
• Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.

  2004cites this paper
• Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic Entity: An Analysis of 32 Cases and a Comprehensive Review of the Literature

  2004cites this paper
• Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1367 The Role of Fibroblast Growth Factor 23 in Phosphate Homeostasis

  2004cites this paper
• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  2003cites this paper
• Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia.

  2003cites this paper
• The Autosomal Dominant Hypophosphatemic Rickets R176Q Mutation in Fibroblast Growth Factor 23 Resists Proteolytic Cleavage and Enhances in Vivo Biological Potency*

  2003cites this paper
• Extracts from tumors causing oncogenic osteomalacia inhibit phosphate uptake in opossum kidney cells.

  2001cites this paper
• Oncogenic osteomalacia secondary to nasal tumor with decreased urinary excretion of cAMP

  2001cites this paper
• Phosphaturic Mesenchymal Tumor-Induced Rickets

  2000cites this paper